Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07042334 · ClinicalTrials.gov registry record · NA
Aim 3: Pilot Study of a Serious Game to Promote Transition Readiness Skills
A NA study of Congenital Heart Defect and Patient Centered Care, sponsored by University of Utah.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT07042334: Recruiting NA study of Congenital Heart Defect and Patient Centered Care, sponsored by University of Utah.
NCT07042334 is a NA study of Congenital Heart Defect and Patient Centered Care that is actively recruiting participants, run by University of Utah. The registered enrollment target is 150 participants, above the 74-participant average among 4 other Congenital Heart Defect trials with a reported enrollment target (103% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07042334, a NA study of Congenital Heart Defect and Patient Centered Care, is actively recruiting participants, sponsored by University of Utah.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
This study involves testing a new video game designed to support adolescents with congenital heart disease (CHD) in preparing to manage their health independently. The game aims to teach essential skills such as communicating with healthcare providers, understanding medical information, and managing appointments and medications. This small pilot study will evaluate the game's usability, acceptability, and its impact on participants' confidence and preparedness for managing their heart care. Feedback will be collected from adolescent participants, their parents, and healthcare providers, and the study will examine how the game influences communication during clinical visits.
Primary Outcome
Metadata metrics from players interaction with the game will be collected, including the number of game logins. The higher the number the more engagement with the game.
Conditions Studied
Interventions
- BEHAVIORAL Serious game for transition readiness
Study Locations (1)
Utah
- Primary Children's Hospital and University of Utah Health - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2026-01-22 |
| Est. Completion | 2026-08 |
| Phase | NA |
What NCT07042334 shows while recruiting
NCT07042334 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, above the 74-participant average among 4 other Congenital Heart Defect trials with a reported enrollment target (103% higher).
The record links to 6 conditions, with Congenital Heart Defect appearing as the primary indexed condition, and to 1 intervention - of which Serious game for transition readiness is the first listed.
NCT07042334 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT07042334 about?
NCT07042334 is a clinical study titled "Aim 3: Pilot Study of a Serious Game to Promote Transition Readiness Skills". This study involves testing a new video game designed to support adolescents with congenital heart disease (CHD) in preparing to manage their health independently. The game aims to teach essential skills such as communicating with healthcare providers, understanding medical information, and managing...
What is the current status of trial NCT07042334?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2026-01-22. Estimated completion is 2026-08.
What conditions does trial NCT07042334 study?
This clinical trial studies the following conditions: Congenital Heart Defect, Patient Centered Care, Congenital Heart Disease in Adolescence, Serious Games, Transition-age Youth.
What interventions are being tested in trial NCT07042334?
The interventions under investigation include: Serious game for transition readiness (BEHAVIORAL).
Who is sponsoring clinical trial NCT07042334?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07042334 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congenital Heart Defect
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Peer Coaching Intervention in Young Adults With Congenital Heart Disease
ACTIVE NOT RECRUITING · NA
-
Improving Patient and Family Health Using Family-Centered Outcomes and Shared Decision-Making
ACTIVE NOT RECRUITING · NA
-
XFM: (X-ray Fused With MRI) Guided Cardiac Catheterization
COMPLETED · NA
-
Clinical Readiness Skin Punch Biopsy Sample Collections
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI